Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  Laboratory Corporation of America Holdings    LH

LABORATORY CORPORATION OF AMERICA HOLDIN

(LH)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsPress ReleasesOfficial PublicationsSector newsAnalyst Recommendations

LABORATORY CORP OF AMERICA HOLDINGS : Change in Directors or Principal Officers, Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)

share with twitter share with LinkedIn share with facebook
share via e-mail
0
11/26/2019 | 08:47am EST

Item 5.02. Departure of Directors or Principal Officers; Election of Directors;

           Appointment of Principal Officers.


Laboratory Corporation of America® Holdings ("LabCorp") today announced that on November 22, 2019, LabCorp's Board of Directors appointed Jeffrey A. Davis as a member of the Board of Directors, effective December 1, 2019. Mr. Davis will also serve on the Audit Committee and the Quality and Compliance Committee of the Board of Directors. Mr. Davis will be entitled to receive compensation for his service on the Board of Directors consistent with LabCorp's director compensation program, as described in LabCorp's most recent proxy statement, filed with the Securities and Exchange Commission on March 29, 2019.

Mr. Davis currently serves as Executive Vice President and Chief Financial Officer of Qurate Retail Group, and prior to that served as Executive Vice President and Chief Financial Officer of J. C. Penney Company Inc. Mr. Davis has more than 30 years of experience, including CFO roles at companies such as Darden Restaurants Inc. and Walmart U.S.

Item 7.01. Regulation FD.

On November 26, 2019, LabCorp issued a press release announcing the appointment of Mr. Davis. A copy of that press release is attached to this current report as Exhibit 99.1.

Item 9.01. Financial Statements and Exhibits.

(d) Exhibits.

  99.1        Press Release dated November 26, 2019 issued by Laboratory Corporation
            of America Holdings.

  104       Cover Page Interactive Data File (embedded within the Inline XBRL
            document).

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses

share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on LABORATORY CORPORATION OF
01/22LABORATORY OF AMERICA : LabCorp Earns 100 Percent on Human Rights Campaign Found..
AQ
01/21LABCORP : Earns 100 Percent on Human Rights Campaign Foundation's Annual Scoreca..
BU
01/15LABORATORY OF AMERICA : LabCorp to Adopt Thermo Fisher Scientific's Ion Torrent ..
AQ
01/14LABORATORY OF AMERICA : LabCorp to Adopt Thermo Fisher Scientific's Ion Torrent ..
BU
01/14LABORATORY CORP OF AMERICA HOLDINGS : Regulation FD Disclosure (form 8-K)
AQ
01/13LABCORP : to Announce Fourth Quarter and Full Year 2019 Financial Results on Feb..
BU
01/13LABCORP : and Covance Launch Extensive Preclinical, Clinical and Post-Approval C..
BU
01/10LABORATORY OF AMERICA : Cautionary Statement Regarding Forward-Looking Statement..
PU
01/06LABORATORY CORP OF AMERICA HOLDINGS : Financial Statements and Exhibits (form 8-..
AQ
01/06LABCORP : is Scheduled to Present at the 38th Annual J.P. Morgan Healthcare Conf..
BU
More news